Clinical Trial Update: Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjunctive topiramate for obsessive-compulsive disorder. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: University of Florida | Conditions: Obsessive-Compulsive Disorder | Phase 3 | Status: COMPLETED